Seven new tips for businesses in consumer sales

ACM is still actively enforcing compliance with consumer rules. This blog addresses the latest developments and provides seven tips. Read more >

Monopolies and dominant positions: focus on pharma & big tech

The Commission and ACM remain critical of pharma and big tech companies. In this blog we address the developments regarding the prohibition on abuse of dominant positions. Read more >

Agri-food: Unfair Commercial Practices Act curbs purchasing power; more opportunities for sustainability agreements

A new era is dawning in the agri-food sector. ACM has been given a new enforcement instrument to take action against the purchasing power of retailers, and the sector will have more opportunities for sustainability initiatives. Read more >

New rules for distribution agreements

Beware of dual distribution and restrictions on price comparison sites. Read more >

Franchise and competition – The new Vertical Block Exemption Regulation

The new Vertical Block Exemption Regulation will enter into force on 1 June 2022. This blog addresses the main changes for franchise agreements. Read more >

Will the NZa merger test be changed in 2022? Abolition of healthcare-specific merger test is preferable

The NZa merger test was and remains superfluous. The NZa and ACM would be better advised to focus on real problems in the healthcare sector. Read more >

Competition law and the pharma sector: access to (expensive) medicines on the European and national agenda

Dutch government to take action against expensive medicines, competition authorities target pharmaceutical companies, and NZa provides more clarity on add-on medicines. Read more >
< 1 .. 5 6 7 8 9 10 11 12 13 14 15 .. 37 >

Autumn trends for 2023
Read more >


Please register here for our newsletter.